Supported Employment and Skills Training in Conjunction With Pharmacotherapy in Schizophrenia Patients
The Effectiveness of Supplementing Supported Employment With Behavioral Skills Training
1 other identifier
interventional
107
1 country
2
Brief Summary
This study will compare employment support with behavioral skills training to employment support alone in schizophrenia patients taking either risperidone or olanzapine to determine which is more effective in helping the patients maintain a job.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_4 schizophrenia
Started Jun 2000
Longer than P75 for phase_4 schizophrenia
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2000
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2005
CompletedFirst Submitted
Initial submission to the registry
September 13, 2005
CompletedFirst Posted
Study publicly available on registry
September 16, 2005
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2006
CompletedResults Posted
Study results publicly available
June 10, 2015
CompletedFebruary 9, 2026
November 1, 2005
5 years
September 13, 2005
May 21, 2010
January 20, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Total Weeks Worked
24 months
Secondary Outcomes (1)
Body Mass Index
First 18 months of study
Study Arms (4)
Risperidone Plus Supported Employment
ACTIVE COMPARATOROlanzapine Plus Supported Employment
ACTIVE COMPARATORRisperidone+Supported Employment+Skills
ACTIVE COMPARATOROlanzapine+Supported Employment+Skills
ACTIVE COMPARATORInterventions
Eligibility Criteria
You may qualify if:
- Diagnosis of schizophrenia
- Candidate for maintenance schizophrenia treatment
- Willing to initiate and continue risperidone or olanzapine therapy for the duration of the study
You may not qualify if:
- Any serious medical problems other than schizophrenia that would interfere with the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- National Institute of Mental Health (NIMH)collaborator
- US Department of Veterans Affairscollaborator
- University of California, Los Angeleslead
Study Sites (2)
West Los Angeles Veterans Healthcare Center
Los Angeles, California, 90073, United States
Greater Manchester Mental Health Center
Manchester, New Hampshire, 03104, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Stephen R. Marder, M.D.
- Organization
- Semel Institute at UCLA
Study Officials
- PRINCIPAL INVESTIGATOR
Stephen R. Marder, MD
University of California, Los Angeles
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 13, 2005
First Posted
September 16, 2005
Study Start
June 1, 2000
Primary Completion
June 1, 2005
Study Completion
September 1, 2006
Last Updated
February 9, 2026
Results First Posted
June 10, 2015
Record last verified: 2005-11